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OBJECTIVES The aim of this study was to analyze, in the same group of patients, the relationship between
multiple variables of coronary lesion and results of exercise, dobutamine and dipyridamole
stress echocardiography tests.
BACKGROUND Integrated evaluation of the relation between stress echocardiography results and angio-
graphic variables should include not only the assessment of stenosis severity but also
evaluation of other quantitative and qualitative features of coronary stenosis.
METHODS Study population consisted of 168 (138 male, 30 female, mean age 51 6 9 years) patients, on
whom exercise (Bruce treadmill protocol), dobutamine (up to 40 mcg/kg/min) and dipyrid-
amole (0.84 mg/kg over 10 min) stress echocardiography tests were performed. Stress echocar-
diography test was considered positive for myocardial ischemia when a new wall motion
abnormality was observed. One-vessel coronary stenosis ranging from mild stenosis to complete
obstruction of the vessel was present in 153 patients, and 15 patients had normal coronary arteries.
The observed angiographic variables included particular coronary vessel, stenosis location, the
presence of collaterals, plaque morphology according to Ambrose classification, percent diameter
stenosis and obstruction diameter as assessed by quantitative coronary arteriography.
RESULTS Covariates significantly associated with the results of physical and pharmacological stress tests
included for all three stress modalities presence of collateral circulation, percent diameter
stenosis and obstruction diameter, as well as lesion morphology (p , 0.05 for all, except
collaterals for dobutamine stress test, p 5 0.06). By stepwise multiple logistic regression
analysis, the strongest predictor of the outcome of exercise echocardiography test was only percent
diameter stenosis (p 5 0.0002). However, both dobutamine and particularly dipyridamole stress
echocardiography results were associated not only with stenosis severity - percent diameter stenosis
(dobutamine, p 5 0.04; dipyridamole, p 5 0.003) - but also, and even more strongly, with lesion
morphology (dobutamine, p 5 0.006; dipyridamole, p 5 0.0009). As all of stress echocardiog-
raphy results were significantly associated with percent diameter stenosis, the best angiographic
cutoff in relation to the results of stress echocardiography test was: exercise, 54%; dobutamine, 58%
and dipyridamole, 60% (p , 0.05 vs. exercise).
CONCLUSIONS Integrated evaluation of angiographic variables have shown that the results of dobutamine and
dipyridamole stress echocardiography are not only influenced by stenosis severity but also, and
even more importantly, by plaque morphology. The results of exercise stress echocardiogra-
phy, although separately influenced by plaque morphology, are predominantly influenced by
stenosis severity, due to a stronger exercise capacity in provoking myocardial ischemia in
milder forms of coronary stenosis. (J Am Coll Cardiol 1999;33:717–26) © 1999 by the
American College of Cardiology
The diagnostic value of the vast majority of noninvasive
echocardiographic or nuclear stress tests in detection of
coronary artery disease has been customarily related to
coronary artery stenosis distribution and severity. The def-
inition and description of significant coronary stenosis has
been usually based on visual and, more recently, quantitative
estimation (1–3), regardless of the appreciation that the
pure anatomic-geometric approach renders just one di-
mension of coronary stenosis. In fact, the variables of
coronary stenosis, as plaque morphology and endothelial
function, have shown to be of significant importance in
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coronary artery disease pathophysiology and clinical out-
come (4,5).
Several studies have found a fair relation between coro-
nary stenosis severity as determined by quantitative arteriog-
raphy variables (percent diameter stenosis, minimal luminal
diameter) and the results of stress echocardiography (6–8).
Also, it has been shown that integrated evaluation of the
relation between dipyridamole stress echocardiography re-
sults and angiographic variables includes not only the
assessment of stenosis severity but also the evaluation of
plaque morphology (9). However, it is indecisive whether
the relation between specific type of lesion morphology and
dipyridamole echocardiography result may be extrapolated
to the other physical or pharmacological forms of stress
testing. Thus, the aim of this study was to analyze, in the
same group of patients, the relationship between multiple
variables of coronary lesion and the results of exercise,
dobutamine and dipyridamole stress echocardiography tests.
METHODS
Study population. The initial group consisted of 191
consecutive patients scheduled for coronary angiography on
whom exercise, dobutamine and dipyridamole stress echo-
cardiography tests were performed. None of them suffered
from congestive heart failure, severe congenital or valvular
heart disease, or documented cardiomyopathy. The patients
with severe hypertension (systolic pressure .200 mm Hg
and diastolic pressure .120 mm Hg), recent malignant
ventricular arrhythmia and severe asthmatic or chronic
obstructive pulmonary disease were not considered for the
study, since these conditions represent a contraindication to
dobutamine and dipyridamole stress testing. Stress echocar-
diography tests were performed in random order within two
to three days in patients on their prescribed antianginal
therapy. Our institution’s human use committee approved
the study, and the informed consent was obtained from all
the patients.
Of this initial set of 191 consecutive patients, 23 patients
were ruled out from further analysis because of the presence
of multivessel coronary artery disease which would make
correlation complex and uncertain. The results of exercise,
dobutamine and dipyridamole stress echocardiography test-
ing were analyzed in the remaining 168 patients (mean age
51 6 9 years; range 28 to 71 years; 130 male, 30 female).
Coronary stenosis, ranging from mild to complete obstruc-
tion of the coronary vessel, was found in 153 out of 168
patients. In 15 patients no identifiable lesion was found,
thus the relation between stress echocardiography results
and quantitative and qualitative angiographic features of
coronary stenosis was restricted to 153 patients. Quantita-
tive and qualitative parameters of coronary stenosis evalu-
ated in the analysis included: particular stenotic coronary
artery vessel, stenosis localization, presence of collateral
circulation, obstruction diameter and percent diameter ste-
nosis as determined by quantitative coronary arteriography
and the type of coronary lesion morphology. Coronary
lesion morphology was defined as simple: correspondent to
Ambrose I and IIa classification, including lesions with
smooth and regular borders without intraluminal filling
defects, and complex: correspondent to Ambrose IIb and III
classification, included lesions with irregular, rough borders,
ulceration with or without intraluminal filling defects sug-
gestive of thrombus, as well as long atherosclerotic lesions
with severe narrowing in series (9,10). Of the 168 patients,
40 (24%) had had a previous non-Q wave myocardial
infarction, 44 (26%) had had a Q-wave myocardial infarc-
tion, 73 (44%) had angina pectoris and 11 (7%) patients
complained of atypical chest pain. Stress echocardiography
tests were performed at least 14 days after myocardial
infarction and at least 3 days after stabilization of clinical
symptoms in patients who presented with unstable angina.
In 89% of patients, the clinically prescribed antianginal
medications (single or combined) were continued and were
the same during each stress test. These consisted of nitrates
in 130 (77%) patients, calcium antagonists in 68 (40%)
patients, and beta-adrenergic blocking agents in 52 (31%)
patients. Theophylline and caffeine-containing products
were not allowed for at least 12 hours before the tests.
Stress protocols. Exercise testing was performed according
to the maximal Bruce treadmill protocol. Criteria for inter-
rupting the test were severe chest pain, development of
marked ST segment depression, age-predicted maximal
target heart rate, systolic hypotension (decrease in systolic
blood pressure .20 mm Hg) or hypertension (increase in
systolic blood pressure .220 mm Hg, and diastolic blood
pressure .120 mm Hg), appearance of frequent or complex
ventricular arrhythmia, exercise limiting dyspnea, fatigue,
claudication or other noncardiac symptoms necessitating
cessation of exercise.
Dobutamine was infused intravenously using a mechan-
ical pump, starting at the dose of 5 mcg/kg/min for 3 min,
increasing to 10, 20 and 30 mcg/kg/min at 3 min intervals,
to a maximal rate of 40 mcg/kg/min administered over
5 min. Dipyridamole was infused intravenously at the dose
of 0.56 mg/kg over 5 min, followed by 4 min of no dose, and
then, if the test was still negative, 0.28 mg/kg over 2 min.
The cumulative dose was therefore 0.84 mg/kg over 10 min.
The infusions were stopped before reaching maximal dose
for any of the following reasons: obvious echocardiographic
positivity, progressive and severe angina accompanied by
marked ST segment changes, symptomatic hypotension
(decrease in systolic blood pressure .20 mm Hg accompa-
nied by nausea, sweating, dizziness, etc.) or hypertension
(same criteria as during exercise), severe ECG rhythm or
conduction abnormalities or intolerable symptoms. Intrave-
nous aminophylline (250 mg) and intravenous propranolol
(0.5 mg) were available after dipyridamole and dobutamine
infusions, respectively.
A 12-lead electrocardiogram and blood pressure record-
ing were performed at baseline and thereafter at the end of
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each stress protocol stage or before the premature cessation
of the test. Electrocardiographic tracing was considered
diagnostic for myocardial ischemia in the presence of ST
segment horizontal or downsloping depression of at least
0.1 mV, 0.08 s after J point compared to baseline. Rate-
pressure product was calculated by multiplying systolic
blood pressure and heart rate. All electrocardiographic
results were reviewed without the knowledge of clinical data
or the results of echocardiographic or angiographic findings.
Echocardiographic analyses. Two-dimensional echocar-
diography was performed with the patient in the left lateral
decubitus position, before and immediately after exercise
test and continuously before, during, and after dobutamine
and dipyridamole infusion. At the end of each stage and
when new wall motion abnormalities developed, all views
obtained at baseline were imaged. Following the cessation
of the tests, echocardiographic imaging was continued until
the return of hemodynamic parameters and/or left ventric-
ular wall motion to the basal state. Interpretable echocar-
diograms were obtained in all patients. In each patient the
apical approach (two chamber, four chamber and five
chamber views) as well as parasternal long- and short-axis
views were utilized, depending on the patient’s visually most
useful acoustic window. All echocardiograms were per-
formed using a commercially available imaging system
(Toshiba SSH60A; Diasonics). A stress echocardiography
test was interpreted from the off line digitized videotapes
(ImageView, ATL), having these images, at rest and peak
stress pharmacological test, as well as rest and immediate
post exercise test, displayed in split screen cine-loop mode.
Two observers, unaware of the patient’s clinical data, an-
giography findings or other echocardiographic test results
analyzed the videotapes. For the purpose of analysis the left
ventricular walls were divided into a 16-segment model.
Segmental wall motion was evaluated using the method by
the American Society of Echocardiography (11) as: normal,
hypokinetic, akinetic or dyskinetic. If a consensus in reading
stress echocardiography study could not be reached, the
judgment of a third observer was obtained. A stress echo-
cardiography test was considered positive when new or
worsening of preexisting wall motion abnormality was
observed. Only echocardiographic criteria (a new wall mo-
tion abnormality) were considered as positive tests. We had
previously reported a high level of inter- and intraobserver
reproducibility for the part of the initial group of patients
(12).
Coronary angiography and angiographic analyses. All
the patients underwent selective coronary angiography using
the Judkins technique, within seven days of the stress
echocardiography tests. Multiple views of each coronary
artery were obtained. For the purpose of analysis, after visual
inspection of the coronary artery in all views, the frame of
optimal clarity in the end-diastolic part of cardiac cycle, in
the view best showing coronary stenosis, was selected. The
image was digitized and analyzed with the quantitative
coronary angiography imaging system (Medis CMS, Neth-
erlands, software version 1.11) by an observer unaware of
the patient clinical data and echocardiographic results. For
the purpose of the analysis, we utilized percent diameter
stenosis and obstruction diameter as quantitative parameters
of stenosis severity. Inter- and intraobserver variability of
quantitative coronary arteriography measurement of end-
diastolic approach for 20 randomly assigned patients have
been evaluated by mean signed difference (representing
accuracy) between the repeated measurements 6 standard
deviations of these differences (representing precision) and
correlation coefficient (13). For interobserver variability, the
mean difference (accuracy) 6 standard deviation (precision)
was 0.01 6 0.16 mm, 0.97 6 3.30% and 1.9 6 6.6 mm, for
obstruction diameter, percent diameter stenosis and length
of the lesion, respectively, and the correlation coefficient was
0.94, 0.97 and 0.66 for obstruction diameter, percent
diameter stenosis and length of the lesion, respectively. For
intraobserver variability, the mean difference (accuracy) 6
standard deviation (precision) was 0.03 6 0.19 mm, 0.75 6
3.59% and 1.2 6 7.2 mm for obstruction diameter, percent
diameter stenosis and length of the lesion, respectively and
correlation coefficient was 0.92, 0.96 and 0.62 for obstruc-
tion diameter, percent diameter stenosis and length of the
lesion, respectively. Therefore, the length of the lesion was
not observed in further analysis because of the suboptimal
and not acceptable level of reproducibility (,0.80 correla-
tion coefficient, and low accuracy and precision in absolute
terms). Significant coronary artery stenosis was considered
present when 50% diameter stenosis of at least one major
coronary artery was observed. Stenosis location was evalu-
ated by utilizing a simplified coronary tree schema with the
left main coronary artery, left anterior descending, left
circumflex and right coronary arteries divided into proximal,
middle and distal segments (14). Diagonal, marginal and
other branches were classified as distal (or middle) segments
of left anterior descending and left circumflex, correspond-
ingly. Utilizing quantitative coronary analysis equipment,
magnification of the coronary segment of interest and
qualitative angiographic evaluation was performed accord-
ing to the Ambrose classification (10). The qualitative
evaluation was performed independently by two observers,
and, in case of disagreement, the decision was based on the
judgment of the third more experienced observer (M.O.).
Interobserver variability for plaque morphology evaluation
was 91% while the intraobserver variability was 94%.
Statistical analyses. The data are expressed as mean 6 SD.
Continuous variables were compared using the analyses of
variance and Newman-Keuls procedure; t test for two
independent groups was used where appropriate. Dichoto-
mous variables were compared using a chi-square (McNe-
mar’s test for paired proportions). Calculations of sensitiv-
ity, specificity and diagnostic accuracy were calculated in the
standard manner. A P value less than 0.05 was considered to
be statistically significant. Logistic regression analysis based
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on the maximum-likelihood estimate was used to evaluate
the relation between angiographic variables and the results
of stress echocardiography tests. Categorical stress echocar-
diography results were regarded as the dependent variable,
and all other variables (particular vessel, stenosis location,
presence of collaterals, percent diameter stenosis, obstruc-
tion diameter, lesion morphology, antianginal medication
and presence of resting wall motion abnormality) were
regarded as independent variables, appropriately classified as
quantitative or categorical. To select covariates indepen-
dently associated with stress echocardiography results, sig-
nificant univariate predictors were reassessed by a forward
stepwise multivariate analysis with values for inclusion and
elimination set at p , 0.05. Also, in order to determine the
best angiographic cutoff value for identification of the results
of each stress echocardiography test, we have determined
the point of the maximum difference in achieving sensitivity
and specificity, respectively, based on the probability calcu-
lated out of McNemar’s test. This technique is independent
of definitions of cutoff values. Ninety-five percent confi-
dence intervals were calculated for comparison of predictive
power of the best angiographic cutoff value for each stress
test.
RESULTS
Angiographic characteristics. Significant one-vessel coro-
nary artery disease ($50% diameter stenosis) was present in
128 patients, in 25 patients coronary lesion was ,50%
diameter stenosis and in 15 patients coronary lesion was not
identified. The distribution of affected vessels was: left
anterior descending 5 103 patients, circumflex artery 5 20
patients and right coronary artery 5 30 patients. Proximal
coronary lesion was identified in 74 patients (left anterior
descending coronary artery 5 65, left circumflex 5 4, right
coronary artery 5 5), middle coronary lesion was identified
in 76 patients (left anterior descending coronary artery 5
38, left circumflex 5 16, right coronary artery 5 22), and
distal coronary lesion was identified in 3 patients (all right
coronary artery). The complete obstruction of the coronary
vessel was present in eight patients. Distribution of coronary
stenosis according to quantitatively assessed diameter ste-
nosis was presented in Figure 1. Mean obstruction diameter
was 1.09 6 0.50 mm, and mean percent diameter stenosis
was 64 6 15%. Simple lesion morphology was present in 63
patients (I–28 patients; IIa–35 patients) and complex lesion
morphology was found in 90 patients (IIb–73 patients;
III–17 patients). Collateral circulation was present in 40 and
absent in 113 patients.
Hemodynamics and feasibility. During exercise testing
and dobutamine infusion all observed hemodynamic values
(heart rate, systolic and diastolic blood pressure and rate-
pressure product) increased significantly (p , 0.01), whereas
during dipyridamole infusion only heart rate and rate-
pressure product significantly increased (p , 0.01). By
analysis of variance, heart rate, blood pressure and rate-
pressure product reached significantly higher levels during
exercise than during dobutamine, and also during dipyrid-
amole (peak rate-pressure product: exercise, 268 6 59;
dobutamine 178 6 58; dipyridamole, 132 6 29 mm Hg
xb/min/100; p , 0.01 for all intergroup differences).
The feasibility of exercise, dobutamine and dipyridamole
stress echocardiography tests were 93%, 97% and 99%,
respectively (p 5 NS), i.e., only 2, 5 and 12 patients during
dipyridamole, dobutamine, and exercise were considered to
have nondiagnostic stress test (negative test in patients not
reaching age-predicted heart rate, or not completing full
pharmacological test). The incidence of significant side
effects were highest (16 patients) during dobutamine infu-
sion and included mainly nonsustained ventricular tachycar-
dia and hypotension and/or bradycardia. Significant side
effects during all three stress tests were well controlled by
immediate cessation of the test or administration of specific
antidotes.
Overall diagnostic value of stress echocardiography tests.
The sensitivity of exercise stress echocardiography (83%)
tests for identification of myocardial ischemia was higher
than that of dobutamine (77%) and dipyridamole (61%)
stress echocardiography (p , 0.05 for all intergroup differ-
ences). The new or worsening of preexisting wall motion
abnormalities seen in these patients corresponded always to
the territory of the affected coronary vessel. Specificity was
highest for dipyridamole stress echocardiography (88%)
than that of exercise (77%) and dobutamine (79%) testing,
but the difference did not reach statistical significance (p 5
NS). The diagnostic accuracy of stress echocardiography
tests was as follows: exercise 82%, dobutamine 74% and
dipyridamole 67% (p , 0.05 for all intergroup differences).
Relation between multiple variables of coronary lesion
and stress echocardiography results. Among the angio-
graphical characteristics which are presented in Table 1,
covariates significantly associated with the results of physical
and pharmacological stress echocardiography results in-
cluded for all three stress tests presence of collateral circu-
lation, quantitatively determined percent diameter stenosis
Figure 1. Bar graph showing the distribution of coronary stenosis
and plaque morphology types in 153 patients. Striped columns 5
simple; dotted columns 5 complex.
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and obstruction diameter, as well as lesion morphology (p ,
0.05 for all, except collaterals for dobutamine stress test, p 5
0.06). We have also analyzed in this manner, the value of
previous myocardial infarction with resting wall motion
abnormalities, as well as concomitant beta-blocker and
calcium antagonist therapy during testing, but none of this
clinical covariates were significantly associated with the
outcome of stress test results (exercise: previous infarction,
p 5 0.83; beta-blocker therapy, p 5 0.62; calcium antago-
nists, p 5 0.74; dobutamine: previous infarction, p 5 0.16;
beta-blocker therapy, p 5 0.39; calcium antagonists, p 5
0.52; dipyridamole: previous infarction, p 5 0.76; beta-
blocker therapy, p 5 0.11; calcium antagonists, p 5 0.25).
Stepwise multiple logistic regression analysis was used to
identify the strongest parameter determining stress echocar-
diography results (Table 2). The strongest predictor of the
outcome of exercise echocardiography test was only percent
diameter stenosis (p 5 0.0002, OR adjusted for other
Table 1. Angiographic Covariates Associated with the Outcome of Stress Echocardiography
Tests by Univariate Logistic Regression Analysis
1a. Exercise Stress Echocardiography
Regression
Coefficient
Standard
Error p
Particular coronary artery 0.52
Stenosis localization 0.24
Collaterals 1.22 0.57 0.03
Obstruction diameter 21.50 0.44 0.0006
% Diameter stenosis 0.07 0.02 0.0002
Stenosis morphology 1.32 0.41 0.0012
1b. Dobutamine Stress Echocardiography
Regression
Coefficient
Standard
Error
p
Particular coronary artery 0.77
Stenosis localization 0.11
Collaterals 0.06
Obstruction diameter 21.29 0.40 0.0012
% Diameter stenosis 0.05 0.01 0.0006
Stenosis morphology 1.49 0.37 0.0001
1c. Dipyridamole Stress Echocardiography
Regression
Coefficient
Standard
Error
p
Particular coronary artery 0.42
Stenosis localization 0.54
Collaterals 1.12 0.41 0.007
Obstruction diameter 21.61 0.38 0.0001
% Diameter stenosis 0.07 0.02 , 0.0001
Stenosis morphology 1.78 0.36 , 0.0001
1a 5 exercise; 1b 5 dobutamine; 1c 5 dipyridamole.
Table 2. Multivariate Predictors of the Outcome of Stress Echocardiography Tests by Logistic
Regression Analysis
Variable
Standardized
Coefficient
Standard
Error p
Adjusted
OR
Correct
Classification
Rate
Exercise
% Diameter stenosis 0.07 0.02 0.0002 1.07 78%
Dobutamine
% Diameter stenosis 0.03 0.02 0.04 1.03 69%
Stenosis morphology 1.12 0.40 0.006 3.07 73%
Dipyridamole
% Diameter stenosis 0.05 0.02 0.003 1.05 71%
Stenosis morphology 1.29 0.39 0.0009 3.64 73%
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variables in the model 1.07). However, both dobutamine
and particularly dipyridamole stress echocardiography re-
sults were associated not only with stenosis severity—
percent diameter stenosis (dobutamine, p 5 0.04, adjusted
OR 1.03; dipyridamole, p 5 0.003, adjusted OR 1.05) but
also, and even more importantly, with lesion morphology
(dobutamine, p 5 0.006, adjusted OR 3.07; dipyridamole,
p 5 0.0009, adjusted OR 3.64).
As all of stress echocardiography results were significantly
associated with percent diameter stenosis, in Figure 2 we
have presented the relation between sensitivity and speci-
ficity for each of the angiographic indexes as a function of
stenosis severity. The best angiographic cutoff in relation to
the outcome of stress echocardiography test was exercise,
54% (95% CI, 49-57%, diagnostic accuracy 78%), dobut-
amine, 58% (55% CI, 55-61%, diagnostic accuracy 69%)
and dipyridamole, 60% (95% CI, 59-63%, diagnostic accu-
racy 69%; p , 0.05 vs. exercise).
Diagnostic value in relation to lesion morphology. Sen-
sitivity of exercise, dobutamine and dipyridamole echocar-
diography in patients with simple plaque morphology was
77%, 56% and 40%, respectively (p , 0.05 for all intergroup
differences). Sensitivity of exercise, dobutamine and dipyr-
idamole in patients with complex plaque morphology was
88%, 82% and 74%, respectively (p 5 0.014 for exercise vs.
dipyridamole). Furthermore, sensitivity of dipyridamole was
significantly (p , 0.001) higher in the group of patients
with complex, rather than simple, lesion morphology. Sen-
sitivity of dobutamine was also higher in the group of
patients with complex plaque morphology (p 5 0.003)
while the sensitivity of exercise was higher in the complex
morphology group, but the difference did not reach statis-
tical significance (Fig. 3).
DISCUSSION
The principal finding of this study is that the results of
pharmacological stress echocardiography test for detection
of myocardial ischemia are dependent not only on absolute
stenosis severity, but also, and even more importantly, on
the morphological pattern of the lesion. Our results are
emphasizing and extending the findings of the previous
study (9) showing that dipyridamole as well as dobutamine
exert more frequently myocardial ischemia in the patients
with complex coronary lesion morphology. The results of
exercise echocardiography test, although separately influ-
Figure 2. Relation between the sensitivity (solid triangles), spec-
ificity (asterisks) and diagnostic accuracy (solid squares) of the
exercise (A), dobutamine (B), and dipyridamole (C) stress echo-
cardiography as a function of quantitatively assessed percent
diameter stenosis (n 5 153). The best angiographic cutoff value
with 95% confidence intervals (CI) for each stress echocardiogra-
phy test is presented.
Figure 3. Bar graph showing the sensitivity of exercise (Ex),
dobutamine (Dob) and dipyridamole (Dip) in the patients with
simple and complex lesion morphology. Sensitivity of dipyrida-
mole and dobutamine was significantly higher (p , 0.01) in the
group of patients with complex lesion morphology. There was a
significant difference between all three stress echocardiography
tests (p , 0.05) for simple lesion types while for complex lesions
the difference was statistically significant (p 5 0.014) only between
exercise and dipyridamole.
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enced by plaque morphology, are predominantly influenced
by coronary stenosis severity.
Relation between stress echocardiography results and
lesion morphology. The mechanism of provoking myocar-
dial ischemia of dipyridamole on one side, and dobutamine
and exercise on the other, is different: dipyridamole is
reducing myocardial supply through flow maldistribution
phenomenon, while the exercise and dobutamine causes
myocardial ischemia through a marked increase in myocar-
dial oxygen demand (15–17). Due to the different mecha-
nism of action, which may induce different degrees of
myocardial supply-demand mismatch, the ischemic poten-
tial of the respective tests is different. The previous findings
have shown that the diagnostic potential is higher for
exercise, than dobutamine and dipyridamole (12,15,18).
With appreciation that coronary stenosis severity is not the
only variable of coronary stenosis, it is suggestive that
ischemic threshold is not the same for simple and complex
coronary lesions. In fact for any given stenosis severity, the
ischemic threshold may be different and dependent not only
on anatomic severity but also on morphologic characteris-
tics. It was noted that in the presence of moderate reduction
in coronary reserve, the flow maldistribution provoked by
dipyridamole might not occur or might not be severe
enough to induce subendocardial ischemia (18,19). Thus,
dobutamine and particularly dipyridamole with a lower
ischemic potential may not reach ischemic ceiling in the
presence of simple lesion morphology, while exercise may
achieve it due to the higher inherent ischemic potential. On
the other side in patients with a complex lesion of similar
severity, the ischemic ceiling may be reached by all three
tests due to the lower ischemic threshold of the lesion.
Mechanism of ischemia. Arteriolar dilation induced by
physical or pharmacological stress consequently increases
blood flow through the coronary artery in order to provide
balance between myocardial demand and supply. However,
in the presence of coronary stenosis, an increase in flow is
accompanied by a pressure fall across the stenosis, and from
the fluid dynamics point of view the magnitude of these
changes is mostly dependent on the tube diameter or, in this
case, stenosis diameter. Thus, the sensitivity of diagnostic
tests would depend on their own ischemic potential and
stenosis severity. However, it is suggestive from our results
that the coronary stenosis morphology may significantly
influence the results of pharmacological stress testing. This
may be explained partly by the previous report showing that
complex coronary stenosis morphology are associated with
more profound endothelial damage (20,21), i.e., loss of
endothelial integrity in complex lesions will reduce local
plaque vasodilatation properties increasing the pressure drop
across the stenosis (22). In addition, by fluid dynamics, the
pressure drop across the stenosis will be higher in presence
of complex lesion morphology due to the higher energy loss
in this type of lesion (23). Thus, the lower ischemic
threshold of complex lesions may be the consequence of the
higher pressure drop across this morphological type of
lesions resulting from the combined biological (endothelium
dependent) and mechanical factors.
Comparison to previous studies. The application of quan-
titative coronary arteriography has made it possible to
objectively study angiographic images, and it has become
the main methodological tool in a number of coronary artery
disease investigations (24). Bartunek et al. (8) have shown
that the magnitude of wall motion abnormalities induced by
dobutamine infusion correlates well with angiographic in-
dexes of stenosis severity even though a wide scatter was
observed. However, they have not found any relation
between qualitative descriptors of stenosis morphology and
degree of dyssynergy. Also, Baptista et al. (7) in the study of
relation between dobutamine-atropine stress echocardiog-
raphy results and quantitative features of stenosis have
presented a nice relation between them with the angio-
graphic cutoff value best predicting the development of wall
motion abnormalities of 52%. This is in concordance with
our findings on dobutamine stress echocardiography test
with angiographic cutoff point at 58% diameter stenosis, as
the addition of atropine to dobutamine negative patients
would identify less severe coronary stenosis. However,
Heyman et al. (25) in patients with nonocclusive single-
vessel disease, have not found association between complex
type coronary stenosis and greater vulnerability to
dobutamine-atropine induced ischemia. Most importantly,
in the study comparing the dipyridamole stress echocardi-
ography findings and qualitative features of the lesion (9),
Lu et al. have found that dipyridamole sensitivity was
associated with complex type coronary morphology, indi-
cating that physiological consequences of a stenosis cannot
always be predicted with a simple anatomic-geometric
approach. The findings of our study are correspondent to
their results, and even more, extrapolated to other investi-
gated test modalities. Varga et al. (26) have confirmed the
relation between complex lesion morphology and dipyrida-
mole echocardiography test positivity. On the other hand,
less severe stenosis was more frequently detected by
dobutamine-atropine stress echocardiography (26). Differ-
ences to our results, in regard to dobutamine, may be related
to addition of atropine in dobutamine negative patients not
reaching target heart rate (in our study group only 14% of
patients reached target heart rate during dobutamine and no
additional atropine was administered), as well as different
selection criteria (multivessel disease included) and smaller
sample size (25,26).
We have shown that collateral circulation is univariately
related significantly to the results of exercise and dipyrida-
mole stress echocardiography and with borderline signifi-
cance for dobutamine echocardiography. After vasodilata-
tion, which may be induced either directly by vasodilating
agent or indirectly by an increase in myocardial oxygen
demand, the flow in the collateral circulation is decreased
because the arteriolar bed of the nonstenotic artery com-
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petes with the arteriolar bed of the stenotic artery that has
already exhausted vasodilatory reserve (15,27). The findings
of borderline significance of collateral circulation for dobut-
amine stress test may be explained by the significantly lower
increase in myocardial oxygen demand (as expressed by
rate-pressure product) during dobutamine infusion in rela-
tion to exercise. In addition, the lack of multivariate
association between collateral circulation and stress echo-
cardiography, particularly vasodilator, test results may be
also due to the evidence that the majority of collateral
circulation is not visible on an angiogram due to inherent
resolution of the angiography. The findings of poor associ-
ation of concomitant beta-blocker therapy with dipyrida-
mole stress results may be explained by the nonexistence of
significant resting and peak hemodynamic difference be-
tween patients on and off beta-blocker therapy—thus, a
number of patients in this study group were most probable
undermedicated with beta-blockers.
Study limitations. This was a retrospective analysis of our
stress echocardiography data (12). However, the data acqui-
sition was prospective and blinded to the present analysis in
which the results of exercise, dobutamine and dipyridamole
echocardiography testing were correlated to quantitative and
qualitative features of coronary stenosis. Although we are
routinely performing third generation stress echocardiogra-
phy protocols (28–32), we have not included these tests in
the study, because of: 1) methodological reasons—in that
case the study population would be comprised of noncon-
secutive and selected group of patients from two study
protocols; 2) conceptual, and more important—the aim of
the study was to evaluate the influence of various stenotic
features on the results of stress echocardiography tests trying
to understand the pathophysiological basis for development
of myocardial ischemia during particular stress agent. Fur-
thermore, the difference in sensitivity and diagnostic accu-
racy between dipyridamole and dobutamine observed in this
study (linked to the skewed nature of the study population
towards one-vessel coronary artery disease) evaporate with
coadministration of atropine, as previously reported (30).
However, further analysis is required to establish the rela-
tion between third generation stress echocardiography pro-
tocols, particularly dipyridamole-atropine and qualitative
features of the coronary lesion.
It has been shown that quantitative arteriography analy-
ses, apart from the technical issues, may show variability
associated with the operators’ and patients’ dependent
features (24). However, it is currently the most reproducible
tool for analyses of angiograms, and with appreciation of the
possible obstacles, many of operators’ dependent limitations
may be overcome. Among basic anatomic parameters which
were considered for analysis, including obstruction diame-
ter, percent diameter stenosis and length, the length of the
lesion was not observed in further analysis due to the
unacceptable level of reproducibility (,80%), as well as the
evidence that angiography systematically underestimates the
size of the plaque. The qualitative features of coronary
stenosis, although appreciated, have been routinely ignored
in clinical classification of coronary stenosis probably due to
the deficiency of quantitative classification criteria with
respective variability (33). The qualitative assessment of
plaque morphology was visual, but adequate level of inter-
and intraobserver agreement has been presented, probably
due to interpretation and visualization of coronary stenosis
from quantitative coronary arteriography system.
The use of echocardiography positivity as an end point
might have important impact on the results of pharmaco-
logical stress techniques, when such a response may be
readily detected during examination, compared with exer-
cise technique, when the patient is more likely to exercise to
a symptomatic end point and then have ischemia identified
after stress. This alone might explain the difference in
sensitivity between exercise and other techniques and the
absence of impact of stenosis morphology on exercise
induced ischemia by multivariate analysis.
Clinical implication. It has been shown that the degree of
arterial obstruction does not correlate with the risk for
subsequent acute ischemic events (34), and the growing
evidence indicates that the degree of coronary obstruction
even precisely measured is just one, maybe not the most
important, feature of coronary stenosis, and that plaque
morphology as well as endothelial function and plaque
composition are other significant determinants of coronary
stenosis. Together, not by themselves, they determine the
outcome of the coronary stenosis. We have shown in this
group of patients with discrete one-vessel coronary stenosis
that dipyridamole, as well as dobutamine, more frequently
exert myocardial ischemia in the patients with complex
coronary lesion morphology. The results of stronger stressor
(exercise) are less, if at all, affected by stenosis lesion
morphology due to the higher ischemic potential and due to
a lack of echocardiography monitoring during exercise
where the overshooting of ischemic threshold during exer-
cise occurs in probably most of the patients. Thus, the
findings of positive, particularly dipyridamole and dobut-
amine, stress echocardiography tests may suggest severe and
complex coronary artery stenosis requiring expeditious fur-
ther diagnostic evaluation as it has been shown that such
lesions are more likely to undergo occlusion and myocardial
infarction (35,36). On the other hand, exercise (or
dobutamine-atropine [25,26]) stress echocardiography
may identify less severe forms of coronary stenosis. Our
results are indirectly supporting the concept that maybe it
is not most important to detect geometrically significant
stenosis but a complex one which may be troublesome in
the follow up period. In expert hands, the results of stress
echocardiography testing may actually provide subtle
“master mind” algorhythm for clinical evaluation and
decision making.
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